Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Antiinfektiøst middel til huden |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
depigmenterende middel |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Pimecrolimus (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Benzyl benzoate (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Teniposide (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Tacalcitol (substance) |
Is a |
False |
Hudmiddel |
Inferred relationship |
Some |
|
undecylensyre og undecylenatsalt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing sulconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing terbinafine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
barbersprit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
neglekosmetik |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Neglelak-resin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
pomade |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
metronidazol 400 mg + nystatin 10.000 enheder tablet + vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Ketoconazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely miconazole 25 milligram/1 gram conventional release oral gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Nystatin 500000 unit oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
nystatin GF/LF/SF 100.000 IE/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Miconazole nitrate 100 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
miconazolnitrat 100 mg/2 % vagitorium + creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
nystatin 100.000 enheder vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine diacetate 200 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,02 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
nystatin 100.000 enheder pastil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat + chlorbutol 0,1/0,5 % mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,2 % mundskyllevæske med pebermyntesmag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Aqueous cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Buffered cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Emulsifying ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Hydrous ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Hydrous wool fat BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Hydrous wool fat ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Simple ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Wool alcohols ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
kamilleekstrakter 10,5 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Unguentum Cocois-forbindelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
lanolin 4 % + zinkoxid 8 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
alphatocopherylacetat 50 IE/g creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
sæbeerstatning + zinkoxid 5 %, cremesæbe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Emollient bath additives |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
sojaolie + blandede lauromacrogoler 82,95/15 % badeolie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
sojaolie 84,75 % badeolie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Ketoconazole 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
miconazolnitrat 2 % pudder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Sulconazole nitrate 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidine 5% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidinacetat pink 0,05 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidin obstetrisk creme 1 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 5 % koncentreret opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidinacetat 1 % pudder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat pink 0,05 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,05 %/0,5 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine diacetate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,05 % topikal væske, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 1,5 %/15 % væske til topikal anvendelse, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat + cetrimid 0,015 %/0,15 % topikal væske, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Brilliant green+crystal violet 0.5%/0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Crystal violet 0.5% paint BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Methylrosanilinium chloride 10 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing clioquinol and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing chlorhexidine and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat opløsning 1,25 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
miconazol 1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 1 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
lidocainhydrochlorid + chlorhexidin 2 %/0,25 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Chlorhexidingluconat 0,5 % i 70% IMS, til hånddesinfektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Tolnaftate 10 mg/g cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,5 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,02 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat pink 0,5 % i 70 % IMS, spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|
chlorhexidingluconat blå 0,5 % i 70 % IMS, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hudmiddel |
Inferred relationship |
Some |
|